Jellagen

自2013年以来，杰拉根从私人投资者和公共来源获得了大量投资，以发展其业务。

自2013年以来，杰拉根从私人投资者和公共来源获得了大量投资，以发展其业务。2018年，杰拉根已将其水母胶原细胞培养产品商业化进行研究，获得了ISO 13485胶原蛋白生产工艺认证，到2018年年底，该公司将雇用超过12名员工。

Jellagen, an innovative marine biotechnology company was co-founded in 2013 by Professor Andrew Mearns Spragg, a Scottish marine biotechnology pioneer. The idea first came to Andrew whilst surfing off the East coast of Scotland in his youth swimming through blooms of jellyfish.